Skip to main content

Table 1 Results of NIHSS and mRS in 50 acute ischemic stroke patients.

From: Blood biomarkers for stroke: the role of thioredoxin in diagnosis and prognosis of acute ischemic stroke

ScaleScoreNumber (50)Percent (%)
NIHSS on admissionMild (1-5)2040%
Moderate (6-13)1734%
Severe (>14)1326%
mRS after 3 months000%
12040%
21326%
31020%
4714%
500%
600%
  1. NIHSS National Institute of Health Stroke Scale, mRS modified Rankin Scale